A new, powerful Citizen Portal experience is ready. Switch now

Committee backs mandatory sickle‑cell continuing education after moving testimony from patients

February 02, 2026 | 2026 Legislature FL, Florida


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Committee backs mandatory sickle‑cell continuing education after moving testimony from patients
Sen. Jones introduced SB 844 to add a one‑time, two‑hour continuing education requirement for licensed physicians and nurses on sickle cell disease care management as part of initial licensure or renewal. The course must be board‑approved and cover evidence‑based treatment protocols across the life course, pain management, genetic counseling, psychosocial care, and family education. Jones and public witnesses emphasized that many clinicians receive little formal training on sickle cell disease and that standardized education would reduce mistreatment, delayed care, and preventable complications.

Public testimony included emotional, direct accounts: 12‑year‑old Shamara Harper described fear of seeking emergency care and asked lawmakers to pass SB 844 so children would receive faster, competent pain treatment; multiple adult speakers and advocates documented instances of mismanagement, labeling as 'drug seekers,' and structural neglect that led to worse outcomes. Several speakers and organizations urged passage; the committee reported the bill favorably as a committee substitute.

Next steps: SB 844 will proceed through the legislative process; implementation would require board approval of curricula and placement in initial licensing and renewal processes.

Don't Miss a Word: See the Full Meeting!

Go beyond summaries. Unlock every video, transcript, and key insight with a Founder Membership.

Get instant access to full meeting videos
Search and clip any phrase from complete transcripts
Receive AI-powered summaries & custom alerts
Enjoy lifetime, unrestricted access to government data
Access Full Meeting

30-day money-back guarantee